Concure Oncology revealed on Friday the addition of Scott Armstrong to its board of directors.
As a member of the company's board, Armstrong supports the advancement of Breast Microseed Treatment as well as continue his advocacy for patient-centric care.
Most recently, Armstrong has served as president and CEO of Group Health Cooperative, anot-for-profit health plan company, positions he has held for 12 years.
Previously at Group Health, Armstrong has worked as VP of Network Services, executive VP/chief administrative officer as well as executive VP/chief operating officer.
Blue Cell Therapeutics appoints Olav Hellebo as board chairman
enGene completes target enrollment for LEGEND pivotal cohort
IDEAYA Biosciences submits IND for IDE892; Targets Phase 1 in 4Q 2025
Karyopharm Therapeutics awards inducement grants to new employees
RaySearch introduces RayIntelligence v2025 to enhance oncology analytics
ImmuPharma files patent for P140 'Immunormalizer' with precision diagnostic for autoimmune diseases
Avacta completes sale of Coris Bioconcept to 3B BlackBio Dx
YD Bio closes business combination and listing on Nasdaq Global Market